<DOC>
	<DOC>NCT01561209</DOC>
	<brief_summary>The objective of this prospective randomized and controlled study is to evaluate the efficacy and safety of low dose of amitriptyline (5 mg) in the management of chronic neck pain.</brief_summary>
	<brief_title>Low Doses Amitriptyline &amp; Chronic Neck Pain</brief_title>
	<detailed_description>Patients with chronic neck pain, lasting since at least 3 months, are recruited from our pain clinic. After verification of inclusion and exclusion criteria, patients consenting to enter the study are assigned randomly to one of the following groups: 1-Amitriptyline 5 mg for 2 months 2- placebo for 2 months. Co-morbidities and other painful conditions are noted, and then clinical evaluation of the patient is performed; pain is assessed according to Visual Analog Scale, anxiety, depression, insomnia and disability are evaluated by adapted scores (Bergen insomnia scale, neck pain disability score, neck pain diary &amp; anxiety and depression score). Patients are followed at 1, 2 and 3 months and outcome measures are assessed.</detailed_description>
	<mesh_term>Neck Pain</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Amitriptyline, perphenazine drug combination</mesh_term>
	<criteria>Chronic neck pain (since more than 3 months, and more than 15 days/month) Normal neurologic exam Xray = normal or loss of lordosis Neurologic signs or symptoms Past history of neck surgery MRI = abnormal findings except for loss of lordosis Past cervical trauma severe depression drug abuse pregnancy Followup not possible cardiac rhythms problems Glaucoma Urinary tract obstruction or prostatism</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>amitryptiline</keyword>
	<keyword>Chronic pain</keyword>
	<keyword>Neck pain</keyword>
</DOC>